R&S Holdings Acquires Residential Addiction Treatment Operator Innovo Detox

October 9, 2026 - 18:20

R&S Holdings, a behavioral health organization that offers addiction treatment and behavioral health services through its subsidiaries, has added a new facility to its growing portfolio. The company confirmed this week that it has acquired Innovo Detox, a residential addiction treatment operator based in Pennsylvania. The move strengthens the organization's presence in the northeastern United States and deepens its ability to serve patients at the earliest stage of recovery.

Innovo Detox provides medically supervised withdrawal management and stabilization services for adults struggling with substance use disorders. The facility offers around the clock clinical care, individualized treatment planning, and a structured environment designed to help patients transition safely into longer term recovery programs. Its team includes physicians, nurses, and behavioral health specialists who manage the complex physical and emotional challenges of detoxification.

R&S Holdings said the acquisition fits its strategy of building a continuum of care that spans detox, residential treatment, outpatient services, and ongoing support. By bringing Innovo Detox into the fold, the organization can now guide patients from initial stabilization through every subsequent phase of treatment without referring them outside its network.

Leadership at both organizations described the deal as a natural alignment of missions. Innovo Detox will continue operating under its existing name and will retain its clinical staff. R&S Holdings plans to invest in infrastructure and expand capacity at the site over the coming months. Financial terms of the transaction were not disclosed. The acquisition reflects a broader trend of consolidation in the addiction treatment sector, as providers seek scale to meet rising demand for behavioral health services across the country.